ReviewClinical ophthalmology (Auckland, N.Z.)2026
Quality of Life Following Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-Analysis.
Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cost Burden and Cost-Effectiveness of Rhegmatogenous Retinal Detachment Repair: A Systematic Review of Economic Evaluations.ClinicoEconomics and outcomes research : CEOR · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To synthesize and quantify quality of life (QoL) outcomes in patients with rhegmatogenous retinal detachment (RRD). Methods: A PRISMA-guided search of Medline, Embase, and Scopus was conducted from database inception to February 8, 2025. Studies reporting QoL outcomes in RRD patients using validated instruments were included. A random-effects meta-analysis was performed and studies were critically appraised using the Joanna Briggs Institute tools. Results: Twenty-four studies involving 1912 participants were included. Most studies were conducted in Europe, Asia, and few in North America. Eighteen studies (75%) utilized the Visual Function Questionnaire 25 (VFQ-25) to assess QoL, while 3 studies (13%) employed the Chinese version of the Low Vision Quality of Life Questionnaire (CLVQoL). Preoperative RRD patients had significantly lower QoL than healthy controls (SMD -5.58 [95% CI -5.82, -5.33]; P<0.01; I2 = 84%). Higher QoL was noted in the RRD patients at 3 months following scleral buckle (SB) or pars plana vitrectomy (PPV) surgery (SMD 0.67 [95% CI 0.45, 0.88]; P=0.10; I2 = 64%). Lower QoL was found in RRD patients 6 months post-surgery compared to healthy controls (SMD -2.99 [95% CI -5.06, -0.92]; P<0.01; I2 = 99%). Lower QoL was found in macula-off compared to macula-on RRD patients 12 months following surgery (SMD -1.08 [95% CI -11.24, 9.07]; P<0.01; I2 = 99%). Higher QoL was found in patients that underwent SB compared to PPV (SMD 2.37 [95% CI -1.66, 6.40] P<0.01; I2 = 92%). Conclusion: Despite surgical advances, RRD patients often experience ongoing challenges affecting recovery. Interventions to optimize care pathways are needed to improve QoL outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.